Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pes University currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, which indicates a very narrow focus for the current prosecution cycle. By having only 1 distinct examiner involved, the university faces a simplified administrative path as there is no need to reconcile different examiner styles across multiple applications.
The prosecution is currently limited to 1 distinct art unit. This concentration suggests that the university's intellectual property in this sector is focused on a specific technological niche within the broader biotechnology field. RAMADAN, OMAR is the busiest examiner for this portfolio and is currently handling 1 busiest examiner pending office action. This examiner is responsible for the entirety of the university's active office actions.
Strategic planning for Pes University should center on the specific preferences of RAMADAN, OMAR. Since this 1 busiest examiner pending action is the only one currently active, the examiner's past behavior will be a primary factor in determining the timeline for the 1 pending office action. The use of 1 distinct art unit further streamlines the process, allowing the applicant to focus on the specific legal standards relevant to that single unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMADAN, OMAR | 1 | 25.4% | +56.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18675163 | DIAGNOSTICHOME KIT TODETECTMIDKINE LEVELIN BLOOD | RAMADAN, OMAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18675163 | DIAGNOSTICHOME KIT TODETECTMIDKINE LEVELIN BLOOD | RAMADAN, OMAR | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18675163 | DIAGNOSTICHOME KIT TODETECTMIDKINE LEVELIN BLOOD | RAMADAN, OMAR | 1678 | §103 | Non-Final OA | — | Pending | May 28, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPes University has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Omar Ramadan has the most, with 1 of Pes University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.